1-7 of 7
Martin Becker
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

In Vivo CRISPR-Cas9 Screens in PDX Models Reveals ADAM10 As Novel Therapeutic Target in Acute Leukemia

Ehsan Bahrami, Jan Philipp Schmid, Martin Becker, Anna-Katharina Wirth, Rupert Öllinger, Roland Rad, Binje Vick, Ashok Kumar Jayavelu, Matthias Mann, Tobias Herold, Irmela Jeremias
Journal: Blood
Blood (2021) 138 (Supplement 1): 708.
https://doi.org/10.1182/blood-2021-149658
Published: 2021
Journal Articles

WT1 and DNMT3A Play an Essential Function and Represent Therapeutic Vulnerabilities in Certain AML Samples, As Shown By CRISPR/Cas9 Mediated Knockout in PDX Models In Vivo

Maryam Ghalandary, Yuqiao Gao, Martin Becker, Diana Amend, Klaus H. Metzeler, Maja Rothenberg-Thurley, Irmela Jeremias
Journal: Blood
Blood (2021) 138 (Supplement 1): 377.
https://doi.org/10.1182/blood-2021-150305
Published: 2021
Journal Articles

A CRISPR/Cas9 Library Screen in Patients' Leukemia Cells In Vivo

Ehsan Bahrami, PhD, Martin Becker, PhD, Anna-Katharina Wirth, MSc, Jan Phillip Schmid, MSc, Tobias Herold, MD, Rupert Öllinger, PhD, Roland Rad, Irmela Jeremias, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3945.
https://doi.org/10.1182/blood-2019-124288
Published: 2019
Journal Articles

Association of CXCR4 with IgM and IgD BCR Isotypes: Role in B Cell Malignancies

Eva Gentner, BSc,MSc,PhD, Andrea Nicola Mazzarello, PhD, Martin Becker, PhD, Antonella Nicolò, M.Sc; B.Sc., Valerio Renna, M.Sc.; B.Sc., Nicholas Chiorazzi, MD, Michael Reth, Prof. Dr., Hassan Jumaa, Prof. Dr., Palash Chandra Maity, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1852.
https://doi.org/10.1182/blood-2018-99-116585
Published: 2018
Journal Articles

Bendamustine Induces Higher Remission Rates, Prolongs Progression Free Survival as Well as Time to Next Treatment, and Improves Overall Survival for Patients In Complete Remission without Compromising Quality of Life When Compared to Chlorambucil In First Line Treatment of Chronic Lymphocytic Leukemia

Wolfgang Ulrich Knauf, MD, Toshko Lissitchkov, MD, Ali Aldaoud, MD, Anna Marina Liberati, MD, Javier Loscertales, MD, Raoul Herbrecht, Gunnar Juliusson, MD, Gerhard Postner, MD, Liana Gercheva, MD, Stefan Goranov, MD, Martin Becker, MD, Hans-Joerg Fricke, MD, Françoise Huguet, MD, Ilaria Del Guidice, MD, Peter Klein, Karlheinz Merkle, MD, Marco Montillo
Journal: Blood
Blood (2010) 116 (21): 2449.
https://doi.org/10.1182/blood.V116.21.2449.2449
Published: 2010
Journal Articles

Bendamustine in the Treatment of Chronic Lymphocytic Leukemia -Consistent Superiority Over Chlorambucil in Elderly Patients and Across Clinically Defined Risk Groups.

Wolfgang Ulrich Knauf, MD, Toshko Lissitchkov, MD, Ali Aldaoud, MD, Anna Liberati, MD, Javier Loscertales, MD, Raoul Herbrecht, MD, Gunnar Juliusson, MD, Gerhard Postner, MD, Liana Gercheva, MD, Stefan Goranov, MD, Martin Becker, MD, Hans-Joerg Fricke, MD, Francoise Huguet, MD, Ilaria Del Giudice, MD, Peter Klein, Karlheinz Merkle, MD, Marco Montillo, MD
Journal: Blood
Blood (2009) 114 (22): 2367.
https://doi.org/10.1182/blood.V114.22.2367.2367
Published: 2009
Journal Articles

Bendamustine Versus Chlorambucil as First-Line Treatment in B Cell Chronic Lymphocytic Leukemia: An Updated Analysis from An International Phase III Study.

Wolfgang Ulrich Knauf, Toshko Lissitchkov, Ali Aldaoud, Anna Liberati, Javier Loscertales, Roul Herbrecht, Gunnar Juliusson, MD, Gerhard Postner, Liana Gercheva, Stefan Goranov, MD, Martin Becker, Klaus Hoeffken, Francoise Huguet, Robert Foa, MD, Karlheinz Merkle, Marco Montillo
Journal: Blood
Blood (2008) 112 (11): 2091.
https://doi.org/10.1182/blood.V112.11.2091.2091
Published: 2008